Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance

Ebrahim H. Maleki, Ahmad Reza Bahrami, Maryam Moghaddam Matin
ISSN / E-ISSN
— / —
DOI
10.1016/j.gendis.2022.11.025 ↗
Volume · Issue · Pages
11 · 1 · 189-204
Publisher
Elsevier BV
Article URL
https://doi.org/10.1016/j.gendis.2022.11.025 ↗
Article details
Unverified
Publication date (each date has its type and source)
14 Jan 2023
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date14 Jan 2023 OpenAlex

Keywords (as given): intratumoral heterogeneity; cell cycle heterogeneity; treatment resistance; chemoresistance; quiescent cancer cells; cancer stem cells; epithelial-mesenchymal transition; circulating tumor cells; disseminated tumor cells; tumor recurrence; cell cycle

HEC Status at Publication Not the journal's current status

HEC Status at PublicationConclusive
HEC status at publication Recognized W
Based on the recorded HEC dataset applicable to the article's publication date. Listed as W in the HEC list for 2022–23.
Journal
Genes and Diseases
Publication date used
14 Jan 2023 (OpenAlex publication date)
Applicable HEC period
2022–23 (version 2) · 01 Jul 2022 – 30 Jun 2023
Category
W
Recognition status
Recognized (OK_RECORD_FOUND)
Source
hjrs-2022-23 row 3727
Verification status
Verified against source · last verified 16 Oct 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.